Brian Sylvester spoke with Bloomberg Law about Kyle Diamantas’ appointment as acting commissioner of the Food and Drug Administration, highlighting the significance of his legal and regulatory background as the agency faces major policy and operational challenges. The article examines how Kyle, who previously led the FDA’s Human Foods Program, will oversee issues ranging from food safety to pharmaceuticals and vaping amid significant staff turnover at the agency. Brian commented on Diamantas’ leadership style, saying, “He brings a very measured and thoughtful approach to the agency.”
Read the full article.
